FDA 483_RESPONSE - Compound Preferred LLC - March 01, 2017
FDA 483_RESPONSE for Compound Preferred LLC on March 01, 2017. Product: N/A. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483_RESPONSE for Compound Preferred LLC on March 01, 2017. Product: N/A. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Compound Preferred LLCInspection Date
March 1, 2017
Product Type
Office
Seattle District OfficeID: 0913ec67-3f8d-46ce-96f1-8444c3be3e62
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox